Three-dimensional pharmacophore hypotheses for the locust neuronal octopamine receptor (OAR3). Part 2: Agonists

Bioorganic and Medicinal Chemistry

Volumn 7, Issue 7, 1999, Pages 1437-1443

  Hirashima, Akinori ^a   Pan, Canping ^b   Kuwano, Eiichi ^a   Taniguchi, Eiji ^a   Eto, Morifusa ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Catalyst; Locusta migratoria; Octopamine agonist; Pharmacophore; Receptor hypothesis

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR AFFECTING AGENT; AMITRIPTYLINE; ANTAZOLINE; CYPROHEPTADINE; DESIPRAMINE; GRAMINE; IMIPRAMINE; OCTOPAMINE; OCTOPAMINE RECEPTOR; PHENTOLAMINE; PROMETHAZINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CENTRAL NERVOUS SYSTEM; DRUG SYNTHESIS; LOCUST; NONHUMAN; PHARMACOPHORE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR BINDING;

ANIMALS; EPINEPHRINE; GRASSHOPPERS; HYDROGEN BONDING; IMIDAZOLES; MODELS, CHEMICAL; MODELS, MOLECULAR; PHENTOLAMINE; RECEPTORS, BIOGENIC AMINE; REPRODUCIBILITY OF RESULTS; STRUCTURE-ACTIVITY RELATIONSHIP;

LOCUSTA MIGRATORIA;

EID: 0033012426     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(99)00057-7     Document Type: Article

References (26)

1. Erspamer, V.; Boretti, G. Arch. Int. Pharmacodyn. 1951, 88, 296.
2. Axelrod, J.; Saavedra, J. M. Nature 1977, 265, 501.
3. Evans, P. D. In Comparative Molecular Neurobiology; Heller, S. R., Ed.; Birkhäuser Verlag: Basel, 1993, pp 287-296.
4. Evans, P. D. In Comprehensive Insect Physiology Biochemistry Pharmacology; Kerkut, G. A., Gilbert, G., Eds.; Pergamon Press: Oxford, 1985; Vol 11, pp 499-530.
5. Saavedra, J. M. Handb. Exp. Pharmacol. 1989, 90, 181.
6. Orchard, I.; Ramirez, J. M.; Lange, A. B. Ann. Rev. Entomology 1993, 38, 227.
7. Nathanson, J. A. Mol. Pharmac. 1985, 28, 254.
8. Evans, P. D. J. Physiol. 1981, 318, 99.
9. Roeder, T.; Nathanson, J. A. Neurochem. Res. 1993, 18, 921.
10. Roeder, T.; Gewecke, M. Biochem. Pharm. 1990, 39, 1793.
11. Roeder, T. Life Science 1991, 50, 21.
12. Roeder, T. Br. J. Pharmac. 1995, 114, 210.
13. Roeder, T. Eur. J. Pharmac. 1990, 191, 221.
14. Harmar, A. J.; Horn, A. S. Molec. Pharmac. 1997, 13, 512.
15. Hirashima, A.; Shinkai, K.; Pan, C.; Kuwano, E.; Taniguchi, E.; Eto, M. Pestic. Sci. 1999, 55, 119.
16. Hirashima, A.; Pan, C.; Shinkai, K.; Tomita, J.; Kuwano, E.; Taniguchi, E.; Eto, M. Bioorg. Med. Chem. 1998, 6, 903.
17. Pan, C.; Hirashima, A.; Kuwano, E.; Eto, M. J. Molec. Model. 1997, 3, 455.
18. Smellie, A.; Teig, S. L.; Towbin, P. J. Comp. Chem. 1995, 16, 171.
19. Smellie, A.; Kahn, S. D.; Teig, S. L. J. Chem. Inf. Comp. Sci. 1995, 35, 285.
20. Smellie, A.; Kahn, S. D.; Teig, S. L. J. Chem. Inf. Comp. Sci. 1995, 35, 295.
21. Brooks, B. R.; Brucolleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. J. Comput. Chem. 1983, 4, 187.
22. Greene, J.; Kahn, S.; Savoj, H.; Sprague, P.; Teig, S. J. Chem. Inf. Comput. Sci. 1994, 34, 1297.
23. Fischer, R. In The Design of Experiments; Hafner Publishing: New York, 1996.
24. Hansch, C.; Leo, A. In Exploring QSAR: Fundamentals and Applications in Chemistry and Biochemistry; American Chemical Society: Washington, DC, 1995.
25. Hansch, C.; Fujita, T. J. Am. Chem. Soc. 1964, 86, 1616.
26. Golender, V. E.; Vorpagel, E. R. In 3D-QSAR in Drug Design: Theory, Methods, and Applications; Kubinyi, H., Ed.; ESCOM Science Publishers: The Netherlands, 1993, p 137.